✦ LIBER ✦

Domain organization of the terminal parts in the fibrinogen molecule

✍ Scribed by L.V. Medved'; S.V. Litvinovich; P.L. Privalov

Book ID: 115918250
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 380 KB
Volume: 202
Category: Article
ISSN: 0014-5793
DOI: 10.1016/0014-5793(86)80705-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trytophan residue in polymerization site

Trytophan residue in polymerization site of the carboxyl terminal domain of fibrinogen

✍ A. Shimizu; T. Yano; Y. Saito; Y. Inada 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 426 KB

The role of conformational domain labili

The role of conformational domain lability of fibrinogen molecule in the processes of fibrin formation and fibrinolysis

✍ M. A. Rozenfel’d; V. B. Leonova; M. I. Biryukova 📂 Article 📅 2006 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 148 KB

Amino acid sequence of the N-terminal pa

Amino acid sequence of the N-terminal part of γ-chain in human fibrinogen

✍ Sadaaki Iwanaga; Birger Blombäck; Nils J. Gröndahl; Birgit Hessel; Per Wallén 📂 Article 📅 1968 🏛 Elsevier Science ⚖ 240 KB

Domain organization of the ORF2 C-termin

Domain organization of the ORF2 C-terminal region of the German cockroach retroposon R1

✍ A. S. Kagramanova; T. V. Kapelinskaya; A. L. Korolev; D. V. Mukha 📂 Article 📅 2010 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 541 KB

Four states of tyrosine residues in the

Four states of tyrosine residues in the fibrinogen molecule

✍ Yuji Inada; Birger Blombäck 📂 Article 📅 1978 🏛 Elsevier Science ⚖ 332 KB

Novel analogues of bradykinin conformati

Novel analogues of bradykinin conformationally restricted in the C-terminal part of the molecule

✍ Małgorzata Śleszyńska; Tomasz H. Wierzba; Krzysztof Malinowski; Lenka Borovičkov 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Abstract In the present work, achiral non‐coded amino acids, N‐(Bzl)‐Gly, X~1~ or X~2~, were substituted at position 7 of the model B~2~ receptor antagonist [D‐Arg^0^, Hyp^3^, Thi^5, 8^, D‐Phe^7^]‐BK. The N‐terminal amino group of the analogues was either free or acylated with 1‐Aca or Aaa. Biol